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ABSTRACT
Patient skin dose measurements were performed at the cardiology department in a hospital in Penang, Malaysia using 
EDR films during coronary angiography (CA) procedures. The EDR2 film was first characterized in terms of dose and 
energy dependence as well reproducibility. For patient dose measurements, the films were placed on the table underneath 
the patient for an under couch tube position. A total of 27 CA procedures were studied. Results for peak skin doses (PSD) 
ranged from 35 to 684 mGy while the dose area product (DAP) values were from 5.5 to 93.1 Gy cm2. DAP correlated 
reasonably with PSD for CA procedure (R2= 0.8212). The highest PSD value in this study is below the threshold dose value 
of 2 Gy for early transient skin injury recommended by the Food and Drug Administration (FDA 1994).
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ABSTRAK
Pengukuran sinaran dos pesakit telah dijalankan di bahagian kardiologi, sebuah hospital di Pulau Pinang, Malaysia 
dengan menggunakan filem EDR2 semasa menjalankan prosedur koronari angiografi (CA). Pencirian filem EDR2 pada 
mulanya dilakukan dalam sebutan kebergantungan dos dan tenaga dan juga keupayaan kebolehpenghasilan semula. Untuk 
mengukur dos pesakit, filem EDR2 diletakkan di atas meja dan di bawah badan pesakit dengan tiub X-ray yang terletak 
di bawah meja. Sebanyak 27 prosedur CA dikaji. Keputusan nilai puncak dos kulit (PSD) adalah dalam julat 35 – 684 
mGy, sementara pendaraban dos dengan luas (DAP) pula adalah dalam julat 5.5 – 93.1 Gy cm2. DAP berkorelasi secara 
wajar dengan PSD dalam prosedur CA (R2 = 0.8212). Nilai PSD maxima di dalam penyelidikan ini adalah di bawah nilai 
ambang dos 2 Gy untuk kecederaan kulit yang dicadangkan oleh Pentadbiran Makanan dan Ubat-ubatan (FDA 1994). 
Kata kunci: Filem EDR2; intervensi kardiologi; pendaraban dos dengan luas; puncak dos kulit 
of patient dose especially for dynamic procedures such 
as interventional procedures where the X-ray irradiation 
area to the patient and projection direction of the X-ray 
beam are continuously varying. DAP is also convenient for 
estimating stochastic risk for patient (Le-Heron et al. 1992; 
McParland et al. 1998). However, DAP cannot be used to 
evaluate deterministic risk because DAP cannot provide 
information about the most irradiated area in the patient 
skin. Therefore, direct measure of patient entrance skin 
doses such as PSD is necessary to evaluate the deterministic 
effect. 
 Many types of slow radiographic films have been 
introduced to directly mapping patient skin doses to 
determine the probability of a possible injury. Slow films 
such as Kodak X Omat V and EDR2 (extended dose range) 
have been successfully used to measure patient skin dose 
(Guibelalde et al. 2003; Morrell et al. 2006; Vano et al. 
1997). Silver halide films are sensitive to room light and 
require wet chemical processing and also cannot give 
online information. However these films are cheaper than 
gafchromic film which requires no chemical processing and 
relatively insensitive to room light. EDR2 film unlike Kodak 
X Omat film with has a wider dose range and is good to 
estimate skin dose distributions in coronary angiography 
INTRODUCTION
Interventional coronary angiography (CA) procedure is 
the first step in the diagnosis of cardiovascular disease. 
Here a patient is injected with a contrast media through 
a catheter and the blood vessels in the anatomical region 
of the heart are then highlighted on a sequence of radio 
graphical images to detect the narrowing of coronary 
arteries (Morrish et al. 2008). CA procedures are known 
to give high radiation doses to patients as the procedures 
involve long fluoroscopy times and several cine runs. This 
is of concern as the number of angiographic studies has 
increased dramatically in Malaysia (Ng et al. 1999; Sapiin 
et al. 2004). The extensive use of X-rays in this technique 
results in an increase risk of deterministic effects.
 To determine the radiation exposure to a patient, 
some dosimetric techniques have been investigated by 
previous authors (Balter et al. 2006; Betsou et al. 1998; 
Canne et al. 2006; Delichas et al. 2005; Dogan et al. 2008; 
Fletcer et al. 2002). Research on patient dose evaluations 
in interventional cardiology mainly focuses on the 
measurement or the estimation of two basic parameters. 
They are dose area product (DAP) and the peak skin dose 
(PSD) over the most irradiated patient area. DAP is the 
most convenient method for the indirect measurement 
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(CA), where the peak skin dose is normally below 1Gy. 
Guibelalde et al. (2003) successfully used it to measure 
peak skin dose up to 1400 mGy for patients undergoing 
CA and percutaneous transluminal coronary angioplasty 
(PTCA) procedures.
 Because there is a limited patient dose data during 
CA procedures in Malaysia, the main purpose of this study 
was to determine patient skin dose using Kodak EDR2 
films. The performance of the film was first characterized 
in terms of dose, energy dependence and reproducibility. 
Patient dose measurements were then performed at a local 
private hospital in Penang. It is also quite common for the 
patients to decide on PTCA at a later date due to cost. It is 
then necessary to assess and record the dose during the 
CA.
MATERIALS AND METHODS
CHARACTERIzATION OF EDR2 FILM
Kodak EDR2 film (Eastman Kodak, Rochester, New York) 
is a low sensitive film and is available in 25.4 cm × 30.5 
cm sheets. It belongs to the line of Kodak Ready-Pack 
products. Kodak EDR2 films are pre-wrapped in light proof 
paper and are ready to use with an exposure range from 
25 cGy to 1000 cGy. The film is sufficiently large to cover 
most of the radiation fields in CA procedures. The film is 
relatively insensitive to the X-ray energies normally used 
in radiotherapy.
 Exact dose responses of EDR2 are a function of facility 
dependent factors such as processing conditions (processing 
time, processing temperature, processing equipment, 
processing chemistry), the density sampling (digitizer 
equipment and calibration) and exposure monitoring 
equipment. For characterization of film, the large film was 
cut into 6 pieces; each piece was sealed in the original 
light-tight envelopes in the darkroom.
 As in all films it was first necessary to characterize 
the EDR2 film for dose, energy and dose rate dependence 
as well as reproducibility. The dose-response of EDR2 film 
could change from film to film as it is strongly influenced 
by processing conditions. Thus, the EDR2 for dose-response 
calibration curve needs to be determined and verified 
simultaneously with the EDR2 used for patient dosimetry 
to obtain reliable reading. 
 Since many lot of interventional procedures were 
performed daily in the cardiac laboratory, it was not easily 
available to calibrate EDR2 film using the Philips Integris 
HM3000 interventional unit. To avoid interruption of the 
cardiac laboratory operation, the EDR2 film calibration was 
performed using the Toshiba X-ray Radiography system 
model KXO-15R at the Medical Physics department in 
Universiti Sains Malaysia (USM) instead of at the local 
hospital. Therefore, to ensure that the interventional 
unit and X-ray radiography system gave the same dose-
response calibration curve, the EDR2 film was calibrated 
with both the X-ray systems.
  In the Toshiba X-Ray Radiography system, EDR2 films 
were positioned on top of a 30 cm × 30 cm with a 10 cm 
thick Perspex phantom to provide sufficient backscatter. 
The backscatter was found not to change after 8 cm 
thickness. The films were positioned close to the X-ray 
tube with source to detector distance (SDD) 33cm, along 
the central axis. At this closest distance, the radiation dose 
given to the film was sufficiently high as those given in 
CA procedures. The film could be irradiated at only one 
distance. Hence the dose rate could not be studied on the 
X-ray system. 
 A 1cc flat ionization chamber type 77337 (PTW, 
Freiburg) was positioned behind the EDR2 films, in the 
center area and used to measure air kerma delivered to 
EDR2 films. According to the manufacturer’s guideline, 
the ion chamber which was connected to the PTW UNIDOS 
electrometer has a total uncertainty of ±5 %. 
 In this X-ray system, the energy dependence of EDR2 
film from was evaluated from 60 kVp to 120 kVp (the 
half value layer, HVL, was between 2.0 mmAl and 3.8 
mmAl) which are typical kVp values used in the clinical 
interventional procedures. A series of known doses in the 
range of about 150 mGy to 850 mGy were given at these 
X-ray energies. To study the reproducibility, the EDR2 films 
were irradiated on 3 different days at energy range from 
60 to 120 kVp. The development of EDR2 films was also 
carried out on 3 different days.
 In the Philips Integris HM3000 Interventional unit 
which has an undercouch system, the EDR2 films were 
positioned below a 30 cm × 30 cm and a 10 cm thick 
Perspex phantom. The ionization chamber was positioned 
on top of the film in the center area. The Perspex phantom 
has a holder to accommodate the ion chamber. To maximize 
the dose rate and to reduce the time of irradiation of films, 
the films were placed as close as possible to the source to 
detector distance (SDD) of 52 cm. The calibration between 
Toshiba X-ray Radiography System and Interventional Unit 
using EDR2 film were evaluated at radiation doses between 
10 to 600 mGy with a 10 cm × 10 cm field size. The selected 
X-ray energy was 80 kVp. For the interventional unit, the 
HVL at 90 kVp is 3.8 mmAl.
 The irradiated EDR2 films irradiated with the Toshiba 
X-ray system and Interventional unit were developed under 
the same processing condition using the Konica Minolta 
automatic medical film processor. All films were stored in 
a light tight box and developed 24 h after exposure to allow 
the response of the film to stabilise. The optical density 
was measured with a X-rite 301 densitometer which had 
a reproducibility of ± 1%. 
 The dose (D) was calculated from the optical density 
(OD) using the equation suggested by Morrell and Rogers 
(2004) which is shown below:
  (1)
where OD is the optical density due to x-ray exposure, ODmax 
is the saturation density of the film, ODmin is the base-plus-
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fog and D is the dose and α is a constant obtained from 
the gradient.
 Patient radiation dose was obtained from the straight 
line graph using (1). The high dose in the saturation region 
can be more easily read from this plot. The sensitometric 
curve was obtained using calibrated films each time the 
CA films were developed. 
PATIENT DOSE MEASUREMENTS 
Patient dose measurements were carried out at the 
cardiology department at a local private hospital in Penang. 
The catheterization laboratory in the cardiology department 
has a Philips Integris HM 3000 Interventional Unit (Philips 
Medical System, Best, The Netherlands) equipped with a 
DAP meter and an image intensifier and the system operates 
at a pulsed fluoroscopy of 12.5 film per second. The unit 
had lead curtains below to protect the cardiologists’ legs 
and a ceiling suspended screen to protect the head from 
scattered radiation. The patient selection was random. The 
peak skin doses of 27 patients who underwent coronary 
angiogram (CA) were measured. 
 Relevant data such as DAP value, fluoroscopy time, 
type of procedure, patient gender, weight and age were 
recorded for each procedure. The X-ray unit had passed 
quality control (QC) evaluation. Pulsed fluoroscopy at 12.5 
frames per second (12.5f/s) was used.
 EDR2 films were placed on the table underneath the 
patient for the under table tube position and centered as 
close as possible to the most irradiated area of the patient. 
The films were processed with the Konica Minolta SRX 
101A automatic processor and the optical density was 
read. The peak skin dose was obtained from the film dose-
response calibration curve.
RESULTS AND DISCUSSION
CHARACTERIzATION OF EDR2 FILM
In clinical practice, the dose rates and X-ray energies of 
the interventional unit vary during CA procedures. It is 
then important to determine the response of the EDR2 film 
irradiated under different X-ray energies and dose rates. 
The results obtained from EDR2 films irradiated at different 
X-ray energies are shown in Figure 1.
 For the different energies from 60 to 120 kVp and 
dose range from 150 mGy to 850 mGy, shown in Figure 
1, the dose response of the EDR2 film in terms of optical 
density fitted well to the polynomial line with a regression 
coefficient of R2 = 0.9906. The response of the film is dose 
dependent but energy independent. Thus one calibration 
curve can be used to analyze peak skin doses for different 
patients where different beam qualities are used. 
 The data from the EDR2 film irradiated and developed 
on 3 different days was plotted and is shown in Figure 2. 
Dose range from 10 to 950 mGy was delivered to the EDR2 
films. The quadratic lines for 3 different calibration days 
were different. The high variation in the film response was 
mainly due to changes in processing conditions and in inter-
film emulsion differences (Khan 2003). Thus, it is important 
to calibrate and obtain the dose-response calibration curve 
of the EDR2 when CA films are developed. 
 The dose-response of EDR2 film was studied using the 
Toshiba X-ray radiography system and the Interventional 
Unit. The range of doses 10 to 650 mGy was delivered at 
80 kVp for both systems. Although the kVp was the same 
but the HVL was different for the two systems. The source 
to film distance also differed hence the dose- rates were 
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    FIGURE 1. EDR2 film dose response to different X-ray energies
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not similar. The dose response of the two systems as net 
optical density (OD) against dose as well as the plot of 
–ln   against dose is shown in Figure 3(a) 
and Figure 3(b). Optical density against dose for the two 
different X-ray equipments fitted a quadratic line with a 
good regression coefficient of 0.9975. A straight line was 
fitted passing through the origin with R2 = 0.9894 when 
using the equation 1. However estimating the dose above 
500mGy using either the quadratic equation or the linear 
equation gave a variation of 15 to 25%.
 Hence the dose-response calibration curve of the 
Toshiba X-ray radiography system can be used to obtain 
patient entrance skin dose from the Philips Interventional 
unit. In addition, the film was dose rate independent as the 
dose rates of the two X-ray machines were different. 
PATIENT DOSE MEASUREMENTS
Patients’ data obtained in CA procedures is shown in Table 
1. In the CA procedures, the following values were obtained 
for the different parameters: cine frame, 305 – 1006; 
fluoroscopy time, 0.5 – 5.6 min; cinefluorography time, 
0.38 – 1.34 min; DAP, 5.5 – 93.1 Gy cm2; PSD, 35 – 684 
mGy (including backscatter); mean radiation field size at 
the entrance of the patient, 64 – 139 cm2. The mean DAP 
value per procedure for CA was 25.0 ± 18.6 Gy cm2, the 
exposure time was 1.4 ± 1.1 min for fluoroscopy time and 
0.66 ± 0.23 min for cine time whilst the mean PSD was 
136 ± 142 mGy. Patient 24 from Table 1 was extremely 
complicated as this patient had very high calcium 
concentration in his artery and the cardiologist had a very 
difficult time to mount the catheter into the patient’s artery. 
Long cinefluorography time and various projections were 
used to get better image quality. This invariably increased 
the number of images as well as the DAP value. 
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    FIGURE 2. Dose-response calibration curve for 3 different days
    FIGURE 3. (a)  Dose-response calibration curve from both the Toshiba X-ray radiography and the Interventional 
systems when plotted using net OD and (b) Dose-response calibration curve from both the Toshiba X-ray 
radiography and the Interventional systems when plotted using Morrell and Rogers equation 
(a)
Dose (mGy)
Ne
t O
D
Dose (mGy)
-ln
 ((
OD
ma
x-O
D)
/(O
D m
ax
-O
D m
in))
(b)
  137
TABLE 1. Dosimetric parameters for CA procedures
No of
patients
No 
of images
Fluoroscopy
time (min)
Cine time
(min)
Total
time(min)
DAP
(Gy cm²)
PSD
(mGy)
Mean field
area (cm²)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
534
594
621
308
287
317
na
397
578
305
446
419
417
373
651
591
466
465
643
409
320
479
516
1006
330
843
467
1.0
1.8
0.6
1.2
1.1
1.1
1.7
1.0
0.4
0.5
1.6
1.0
2.4
1.7
5.6
0.8
0.6
0.9
1.6
0.7
1.5
0.5
0.7
0.6
0.6
3.7
2.3
0.71
0.79
0.83
0.41
0.38
0.42
na
0.53
0.77
0.41
0.59
0.56
0.56
0.50
0.87
0.79
0.62
0.62
0.86
0.55
0.43
0.64
0.69
1.34
0.44
1.12
0.62
1.71
2.59
1.43
1.61
1.48
1.52
na
1.53
1.17
0.91
2.19
1.56
2.96
2.20
6.47
1.59
1.22
1.52
2.46
1.25
1.93
1.14
1.39
1.94
1.04
4.82
2.92
18.1
18.1
5.5
30.0
10.9
20.8
na
17.3
15.2
12.8
24.8
16.9
33.1
19.5
67.7
20.3
18.4
21.8
38.1
20.9
13.5
17.2
19.5
93.1
12.6
42.6
21.70
59
74
57
107
35
123
125
82
131
46
119
94
193
116
511
94
82
122
149
123
116
56
47
684
42
210
82
86
96
94
90
87
88
82
76
110
88
77
90
88
81
139
70
64
90
83
63
88
86
100
90
93
93
74
 The distribution of peak skin dose (PSD) for CA 
procedures is shown in Figure 4. The PSD of 24 patients 
were less than 200 mGy, 2 patients had PSD between 500-
700 mGy. If the 2 patients do perform PTCA at a later time, 
they may likely exceed the 2 Gy for early transient skin 
injury. 
 The comparison of the mean DAP value as well as the 
mean effective dose of this study with other studies for 
CA procedures in recent years is shown in Table 2. In this 
study, the mean value of 25.0 Gy cm2 for CA procedure is 
lower than some quoted studies, this may possible due to 
the patient size being relatively smaller than a European 
patient. To convert DAP in Gy cm2 to effective dose in mSv, 
the conversion factor of 0.183 mSv Gy-1 cm-2 calculated 
by Betsou et al (1998) was applied. The mean DAP from 
our measurements gave a mean effective absorbed dose 
of 4.6±3.4 mSv. However patient 24 with the highest DAP 
value would have received an effective dose of 17.0 mSv. 
In UK, the National Radiological Protection Board has 
given effective patient doses of 3-10 mSv for CA (Hart & 
Wall 2002). 
 However the DAP measurement cannot provide 
information regarding the most irradiated area in the 
patient’s skin, so that the radiological risk cannot 
be deduced directly from this value. Therefore the 
measurement of peak skin dose is required.
 The correlation between the DAP and PSD values 
for CA procedures were studied and the results shown 
in Figure 5. Figure 5 show a reasonable correlation (R2 
= 0.8212) between the PSD and DAP values for the CA 
procedures. DAP may be a good indicator of peak skin 
dose in CA procedures when doses are below 800 mGy. 
The relationship between the fluoroscopy time and PSD 
value for CA procedures gave a relatively poor regression 
coefficient of 0.2936, Figure 6(a). The poor regression 
was partly due to patient 24 in Table 1 who had an 
extremely complicated procedure where the fluoroscopy 
time was relatively long. If this patient data was not 
taken into account then the regression coefficient became 
0.6312, Figure 6(b). 
CONCLUSION
EDR2 film was suitable to monitor patient skin doses 
below 1000 mGy which is normally encountered in CA 
procedures. Skin doses in the local hospital were relatively 
low for CA procedures where 93% of patients’ skin doses 
were less than 300 mGy. This excludes the 2 extremely 
complicated procedures. Although EDR2 film is relatively 
cost effective, it has to be calibrated for dose response 
when the CA films are developed. 
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FIGURE 4. Distribution of peak skin dose 
TABLE 2. Published CA values between 1995-2008
References Year Mean DAP ( Gy cm2) Mean Effective Dose 
Vano et al. 1995 66.5 12.2
Betsou et al.  1998 30.4 5.6
Padovani et al. 1998 39.3 7.2
Van de Putee et al. 2000 60.6 11.1
Tsapaki et al.  2003 47.3  8.7
Morrish et al. 2008 49.9 9.1
This study 2009 25.0±18.6 4.6±3.4
PSD (mGy)
DA
P (
Gy
 cm
2 )
FIGURE 5. Correlation between DAP and PSD
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FIGURE 6. (a) Correlation between fluoroscopy time and PSD and (b) Correlation 
between fluoroscopy time and PSD excluded patient No. 24
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